-
1
Suppression of MCP-1, IFN-γ and IL-6 production of HNSCC ex vivo by pembrolizumab added to docetaxel and cisplatin (TP) exceeding those of TP alone is linked to improved survival
Published 2025-01-01Subjects: “…local and locoregional advanced head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Article